Organization
Houston Methodist Neal Cancer Center
5 abstracts
Abstract
Outcomes of liver transplant recipients with pretransplant malignancies: Insights from a single institution’s experience.Org: University of Minnesota, Houston Methodist Cancer Center, Houston Methodist Hospital, Houston Methodist Neal Cancer Center, Missouri City,
Abstract
5-hydroxymethylcytosine in cell-free DNA as liquid biomarker for immune checkpoint inhibitor therapy in non–small cell lung cancer.Org: Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Houston Methodist Hospital, Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Department of Medical Oncology, Center for Data Intensive Science at the University of Chicago,
Abstract
Factors impacting outcomes in individuals ≥80 years with non-small cell lung cancer (NSCLC): A National Cancer Database (NCDB) analysis.Org: Houston Methodist Neal Cancer Center, Houston Methodist Cancer Center, Houston Methodist Hospital, Department of Pathology and Genomic Medicine,
Abstract
Clinical outcomes of patients with early-stage epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer who underwent reflex molecular testing.Org: Houston Methodist Neal Cancer Center, Houston Methodist Hospital / Department of Pathology and Genomic Medicine,
Abstract
Circulating tumor DNA (ctDNA) and disease recurrence in early stage pancreatic cancer.Org: Houston Methodist Cancer Center, Houston Methodist Neal Cancer Center,